News

Presurgical radiation may curb pancreatic cancer recurrence
Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...
ascopubs.org3d
Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2–positive metastatic pancreatic cancer (mPC ...
Background: Combinations of folinic acid, fluorouracil (5-FU), irinotecan, and oxaliplatin (FOLFIRINOX) along with GN are standard first-line treatment options for mPC. Despite treatment advances, mPC ...